Human iPSC-hepatocyte modeling of alpha-1 antitrypsin heterozygosity reveals metabolic dysregulation and cellular heterogeneity

By sjmartinez • December 9, 2022

Kaserman JE, Werder RB, Wang F, Matte T, Higgins MI, Dodge M, Lindstrom-Vautrin J, Bawa P, Hinds A, Bullitt E, Caballero IS, Shi X, Gerszten RE, Brunetti-Pierri N, Liesa M, Villacorta-Martin C, Hollenberg AN, Kotton DN, Wilson AA. Human iPSC-hepatocyte modeling of alpha-1 antitrypsin heterozygosity reveals metabolic dysregulation and cellular heterogeneity. Cell Rep. 2022 Dec 6;41(10):111775. doi: 10.1016/j.celrep.2022.111775. PMID: 36476855.

Tags: alpha-1 antitrypsin deficiency, cellular heterogeneity, CP: Metabolism, CP: Stem cell research, Endocrinology, ER stress, induced pluripotent stem cells, iPSC-derived hepatocytes, liver fibrosis, metabolic dysregulation, mitochondrial dysfunction, proteostasis, Publications, unfolded protein response

Safety and Efficacy of Repeat Surgery for Recurrent Craniopharyngiomas: A RAPID Consortium Collaboration

Shih RM, Harary M, Bergsneider M, Wang M, Heaney AP, Wu KC, Prevedello DM, Evans JJ, Chicoine MR, Kim AH, Silverstein JM, Karsy M, Van[...]

Longitudinal Outcomes in Immune Checkpoint Inhibitor-Associated Uveitis

Yun JS, Feo A, Chew L, Feng J, Hutchins E, Stein-Merlob AF, Yang EH, Lechner MG, Tsui E. Longitudinal Outcomes in Immune Checkpoint Inhibitor-Associated Uveitis.[...]

Development of insulin resistance in women over the menopause transition

Karlamangla AS, Han WJ, Srikanthan P, Shieh A, Thomas D, Sternfeld B, Hedderson MM, Greendale GA. Development of insulin resistance in women over the menopause[...]